FDA inspection
Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd: FDA inspection ending Jun 2, 2023
FDA inspection 1209415 · No Action Indicated (NAI) · Jinhua
Key facts
| Inspection ID | 1209415 |
|---|---|
| Firm | Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd |
| FEI number | 3008259952 |
| Address | 519 Jiang South Rd, Hengdianzhen Dongyang |
| City | Jinhua |
| Country | China |
| Fiscal year | 2023 |
| Inspection end date | Jun 2, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data